Project: American Community Survey and Decennial Census Support Services
(2019) The ACS conference began with some Census Bureau updates on activities and operations. Steven Dillingham, the Census Bureau Director, expressed the importance the ACS and said “data users are the key to the continuous improvement” of the flagship survey.
Project: Center for Public Information on Population Research (CPIPR)
As coronavirus cases rise in less densely populated states in the Midwest and West, the disease, combined with high levels of obesity in rural America, could pose major challenges for health care systems, suggests Mark Lee at the University of Minnesota.
Project: PACE: Policy, Advocacy, and Communication Enhanced for Population and Reproductive Health
The Baringo County Integrated Development Plan (2018-22) establishes a vision “To be the most attractive, competitive, and resilient county that affords the highest standard of living and security to all its residents.”
Project: Demography and Economics of Aging and Alzheimer’s Disease
The current growth of the population ages 65 and older, driven by the large baby boom generation—those born between 1946 and 1964—is unprecedented in U.S. history. This aging of the U.S. population has brought both challenges and opportunities to the economy, infrastructure, and institutions.
Project: PACE: Policy, Advocacy, and Communication Enhanced for Population and Reproductive Health
The Baringo County Integrated Development Plan (2018-22) establishes a vision “To be the most attractive, competitive, and resilient county that affords the highest standard of living and security to all its residents.”
Project: Center for Public Information on Population Research (CPIPR)
Scientists have long debated the importance of nature versus nurture—genes versus the environment—in shaping the choices people make and the paths their lives take.
Project: Center for Public Information on Population Research (CPIPR)
(2018) The prescription opioid painkillers that helped fuel the surge in U.S. drug overdose deaths were first approved by the Federal Drug Administration in late 1995.